IHT Wealth Management, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
IHT Wealth Management, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$202,432
-15.3%
4,964
+50.8%
0.01%
-38.9%
Q1 2022$239,000
-36.8%
3,292
+2.9%
0.02%
-35.7%
Q4 2021$378,000
+4.1%
3,200
+18.3%
0.03%
-6.7%
Q3 2021$363,000
-65.6%
2,705
-58.4%
0.03%
-55.2%
Q2 2021$1,054,000
+90.9%
6,508
-5.3%
0.07%
+67.5%
Q1 2021$552,000
-30.1%
6,873
-52.7%
0.04%
-39.4%
Q4 2020$790,000
+164.2%
14,531
-3.3%
0.07%
+120.0%
Q3 2020$299,000
+36.5%
15,025
+44.4%
0.03%0.0%
Q2 2020$219,000
+43.1%
10,405
-16.8%
0.03%
+36.4%
Q1 2020$153,000
-15.0%
12,505
+18.7%
0.02%
-26.7%
Q1 2019$180,000
+27.7%
10,534
+2.1%
0.03%
+11.1%
Q4 2018$141,000
-38.7%
10,322
+28.4%
0.03%
-46.0%
Q3 2018$230,000
+1.8%
8,042
-2.4%
0.05%
-13.8%
Q2 2018$226,000
+32.9%
8,2420.0%0.06%
+26.1%
Q1 2018$170,000
+5.6%
8,242
+2.5%
0.05%
+7.0%
Q4 2017$161,000
-31.2%
8,0420.0%0.04%
-57.0%
Q3 2017$234,000
+23300.0%
8,042
-3.9%
0.10%
Q2 2017$1,000
-99.1%
8,370
+1.1%
0.00%
-100.0%
Q1 2017$117,0008,2800.08%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders